Membrane-localized neoantigens predict the efficacy of cancer immunotherapy

Goldberger, Zoe; Hauert, Sylvie; Chang, Kevin; Kurtanich, Trevin; Alpar, Aaron T.; Repond, Grégoire; Wang, Yue; Gomes, Suzana; Krishnakumar, Raga; Siddarth, Prabha; Swartz, Melody A.; Hubbell, Jeffrey A.; Briquez, Priscilla S.

doi:10.1016/j.xcrm.2023.101145

Membrane-localized neoantigens predict the efficacy of cancer immunotherapy

Journal Article · Tue Aug 01 00:00:00 EDT 2023 · Cell Reports Medicine

DOI:https://doi.org/10.1016/j.xcrm.2023.101145· OSTI ID:1996293

Goldberger, Zoe; Hauert, Sylvie; Chang, Kevin; Kurtanich, Trevin; Alpar, Aaron T.; Repond, Grégoire; Wang, Yue; Gomes, Suzana; Krishnakumar, Raga; Siddarth, Prabha; Swartz, Melody A.; Hubbell, Jeffrey A.;

Not Available

View Journal Article

Sponsoring Organization:: USDOE National Nuclear Security Administration (NNSA)

Grant/Contract Number:: NA0003525

OSTI ID:: 1996293

Alternate ID(s):: OSTI ID: 2311393

Journal Information:: Cell Reports Medicine, Journal Name: Cell Reports Medicine Journal Issue: 8 Vol. 4; ISSN 2666-3791

Publisher:: ElsevierCopyright Statement

Country of Publication:: United States

Language:: English

References (47)

The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross-presenting dendritic cells Henning, Petra; Gustafsson, Tobias; Flach, Carl-Fredrik European Journal of Immunology, Vol. 41, Issue 8 https://doi.org/10.1002/eji.201041009	journal	July 2011
Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells Deauvieau, Florence; Ollion, Vincent; Doffin, Anne-Claire International Journal of Cancer, Vol. 136, Issue 5 https://doi.org/10.1002/ijc.29087	journal	August 2014
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment Lengliné, Etienne; Peron, Julien; Vanier, Antoine The Lancet Oncology, Vol. 22, Issue 10 https://doi.org/10.1016/S1470-2045(21)00337-5	journal	October 2021
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer Hellmann, Matthew D.; Nathanson, Tavi; Rizvi, Hira Cancer Cell, Vol. 33, Issue 5 https://doi.org/10.1016/j.ccell.2018.03.018	journal	May 2018
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma Hugo, Willy; Zaretsky, Jesse M.; Sun, Lu Cell, Vol. 165, Issue 1 https://doi.org/10.1016/j.cell.2016.02.065	journal	March 2016
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction Wells, Daniel K.; van Buuren, Marit M.; Dang, Kristen K. Cell, Vol. 183, Issue 3 https://doi.org/10.1016/j.cell.2020.09.015	journal	October 2020
Increased exosome production from tumour cell cultures using the Integra CELLine Culture System Mitchell, J. Paul; Court, Jacqueline; Mason, Malcolm David Journal of Immunological Methods, Vol. 335, Issue 1-2 https://doi.org/10.1016/j.jim.2008.03.001	journal	June 2008
Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy Merritt, Robert E.; Yamada, Reiko E.; Crystal, Ronald G. The Journal of Thoracic and Cardiovascular Surgery, Vol. 127, Issue 2 https://doi.org/10.1016/j.jtcvs.2003.09.007	journal	February 2004
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction Castellino, Flora; Huang, Alex Y.; Altan-Bonnet, Grégoire Nature, Vol. 440, Issue 7086 https://doi.org/10.1038/nature04651	journal	April 2006
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations Tran, Eric; Robbins, Paul F.; Rosenberg, Steven A. Nature Immunology, Vol. 18, Issue 3 https://doi.org/10.1038/ni.3682	journal	March 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Zehir, Ahmet; Benayed, Ryma; Shah, Ronak H. Nature Medicine, Vol. 23, Issue 6 https://doi.org/10.1038/nm.4333	journal	May 2017
Targeting neoantigens to augment antitumour immunity Yarchoan, Mark; Johnson, Burles A.; Lutz, Eric R. Nature Reviews Cancer, Vol. 17, Issue 4 https://doi.org/10.1038/nrc.2016.154	journal	February 2017
The known unknowns of antigen processing and presentation Vyas, Jatin M.; Van der Veen, Annemarthe G.; Ploegh, Hidde L. Nature Reviews Immunology, Vol. 8, Issue 8 https://doi.org/10.1038/nri2368	journal	August 2008
Towards a systems understanding of MHC class I and MHC class II antigen presentation Neefjes, Jacques; Jongsma, Marlieke L. M.; Paul, Petra Nature Reviews Immunology, Vol. 11, Issue 12 https://doi.org/10.1038/nri3084	journal	November 2011
Cross-presentation by dendritic cells Joffre, Olivier P.; Segura, Elodie; Savina, Ariel Nature Reviews Immunology, Vol. 12, Issue 8 https://doi.org/10.1038/nri3254	journal	July 2012
The future of cancer immunotherapy: microenvironment-targeting combinations Murciano-Goroff, Yonina R.; Warner, Allison Betof; Wolchok, Jedd D. Cell Research, Vol. 30, Issue 6 https://doi.org/10.1038/s41422-020-0337-2	journal	May 2020
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome Rusch, Michael; Nakitandwe, Joy; Shurtleff, Sheila Nature Communications, Vol. 9, Issue 1 https://doi.org/10.1038/s41467-018-06485-7	journal	September 2018
A decade of immune-checkpoint inhibitors in cancer therapy Robert, Caroline Nature Communications, Vol. 11, Issue 1 https://doi.org/10.1038/s41467-020-17670-y	journal	July 2020
MHC-II neoantigens shape tumour immunity and response to immunotherapy Alspach, Elise; Lussier, Danielle M.; Miceli, Alexander P. Nature, Vol. 574, Issue 7780 https://doi.org/10.1038/s41586-019-1671-8	journal	October 2019
Tumor mutational load predicts survival after immunotherapy across multiple cancer types Samstein, Robert M.; Lee, Chung-Han; Shoushtari, Alexander N. Nature Genetics, Vol. 51, Issue 2 https://doi.org/10.1038/s41588-018-0312-8	journal	January 2019
Extracellular vesicles in immunomodulation and tumor progression Marar, Carolyn; Starich, Bartholomew; Wirtz, Denis Nature Immunology, Vol. 22, Issue 5 https://doi.org/10.1038/s41590-021-00899-0	journal	March 2021
Genomic correlates of response to immune checkpoint blockade Keenan, Tanya E.; Burke, Kelly P.; Van Allen, Eliezer M. Nature Medicine, Vol. 25, Issue 3 https://doi.org/10.1038/s41591-019-0382-x	journal	March 2019
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma Liu, David; Schilling, Bastian; Liu, Derek Nature Medicine, Vol. 25, Issue 12 https://doi.org/10.1038/s41591-019-0654-5	journal	December 2019
How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer Peters, S.; Reck, M.; Smit, E. F. Annals of Oncology, Vol. 30, Issue 6 https://doi.org/10.1093/annonc/mdz109	journal	June 2019
The Immune Epitope Database (IEDB): 2018 update Vita, Randi; Mahajan, Swapnil; Overton, James A. Nucleic Acids Research, Vol. 47, Issue D1 https://doi.org/10.1093/nar/gky1006	journal	October 2018
CXCL9 and CXCL10 bring the heat to tumors Reschke, Robin; Gajewski, Thomas F. Science Immunology, Vol. 7, Issue 73 https://doi.org/10.1126/sciimmunol.abq6509	journal	July 2022
The hallmarks of successful anticancer immunotherapy Galluzzi, Lorenzo; Chan, Timothy A.; Kroemer, Guido Science Translational Medicine, Vol. 10, Issue 459 https://doi.org/10.1126/scitranslmed.aat7807	journal	September 2018
Pathways of Antigen Processing Blum, Janice S.; Wearsch, Pamela A.; Cresswell, Peter Annual Review of Immunology, Vol. 31, Issue 1 https://doi.org/10.1146/annurev-immunol-032712-095910	journal	March 2013
Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells Corthay, Alexandre; Lundin, Katrin U.; Lorvik, Kristina Berg Cancer Research, Vol. 69, Issue 14 https://doi.org/10.1158/0008-5472.CAN-08-4816	journal	July 2009
Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers Subbiah, Vivek; Puzanov, Igor; Blay, Jean-Yves Cancer Discovery, Vol. 10, Issue 5 https://doi.org/10.1158/2159-8290.CD-19-1265	journal	May 2020
Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow Mayer, Christian Thomas; Ghorbani, Peyman; Nandan, Amrita Blood, Vol. 124, Issue 20 https://doi.org/10.1182/blood-2013-12-545772	journal	November 2014
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations Allegretti, Matteo; Fabi, Alessandra; Buglioni, Simonetta Journal of Experimental & Clinical Cancer Research, Vol. 37, Issue 1 https://doi.org/10.1186/s13046-018-0702-x	journal	March 2018
Role of chemokines in the biology of natural killer cells Robertson, Michael J. Journal of Leukocyte Biology, Vol. 71, Issue 2 https://doi.org/10.1189/jlb.71.2.173	journal	February 2002
Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma Robert, Caroline; Ribas, Antoni; Hamid, Omid Journal of Clinical Oncology, Vol. 36, Issue 17 https://doi.org/10.1200/JCO.2017.75.6270	journal	June 2018
Properties of MHC Class I Presented Peptides That Enhance Immunogenicity Calis, Jorg J. A.; Maybeno, Matt; Greenbaum, Jason A. PLoS Computational Biology, Vol. 9, Issue 10 https://doi.org/10.1371/journal.pcbi.1003266	journal	October 2013
Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system Das, Krishna; Eisel, David; Lenkl, Clarissa PLOS ONE, Vol. 12, Issue 3 https://doi.org/10.1371/journal.pone.0174077	journal	March 2017
Subcellular location of source proteins improves prediction of neoantigens for immunotherapy Castro, Andrea; Kaabinejadian, Saghar; Yari, Hooman The EMBO Journal, Vol. 41, Issue 24 https://doi.org/10.15252/embj.2022111071	journal	October 2022
Engineering Targeting Materials for Therapeutic Cancer Vaccines Briquez, Priscilla S.; Hauert, Sylvie; de Titta, Alexandre Frontiers in Bioengineering and Biotechnology, Vol. 8 https://doi.org/10.3389/fbioe.2020.00019	journal	February 2020
Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells Ferlazzo, Guido; Morandi, Barbara Frontiers in Immunology, Vol. 5 https://doi.org/10.3389/fimmu.2014.00159	journal	April 2014
Cross-presentation of cell-associated antigens by MHC class I in dendritic cell subsets Gutiérrez-Martínez, Enric Frontiers in Immunology, Vol. 6 https://doi.org/10.3389/fimmu.2015.00363	journal	January 2015
Transmembrane Helices Are an Overlooked Source of Major Histocompatibility Complex Class I Epitopes Bianchi, Frans; Textor, Johannes; van den Bogaart, Geert Frontiers in Immunology, Vol. 8 https://doi.org/10.3389/fimmu.2017.01118	journal	September 2017
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy Almagro, Juan C.; Daniels-Wells, Tracy R.; Perez-Tapia, Sonia Mayra Frontiers in Immunology, Vol. 8 https://doi.org/10.3389/fimmu.2017.01751	journal	January 2018
Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells Dionisi, Marco; De Archangelis, Claudia; Battisti, Federico Frontiers in Immunology, Vol. 9 https://doi.org/10.3389/fimmu.2018.02481	journal	November 2018
Cold Tumors: A Therapeutic Challenge for Immunotherapy Bonaventura, Paola; Shekarian, Tala; Alcazer, Vincent Frontiers in Immunology, Vol. 10 https://doi.org/10.3389/fimmu.2019.00168	journal	February 2019
Antigen Cross-Presentation by Macrophages Muntjewerff, Elke M.; Meesters, Luca D.; van den Bogaart, Geert Frontiers in Immunology, Vol. 11 https://doi.org/10.3389/fimmu.2020.01276	journal	July 2020
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence Vaddepally, Raju K.; Kharel, Prakash; Pandey, Ramesh Cancers, Vol. 12, Issue 3 https://doi.org/10.3390/cancers12030738	journal	March 2020
B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice DiLillo, David J.; Yanaba, Koichi; Tedder, Thomas F. The Journal of Immunology, Vol. 184, Issue 7 https://doi.org/10.4049/jimmunol.0903009	journal	April 2010

Similar Records

Immunotherapy for ovarian cancer

Journal Article · Mon Oct 01 00:00:00 EDT 1990 · Current Opinion in Oncology; (United States) · OSTI ID:5265258

The immunobiology and immunotherapy of ovarian cancer

Journal Article · Sat Jun 01 00:00:00 EDT 1991 · Seminars in Oncology; (United States) · OSTI ID:5265259

Membrane-localized neoantigens predict the efficacy of cancer immunotherapy

Citation Formats

References (47)

Similar Records

Related Subjects